| Literature DB >> 15079026 |
H Feldman1, P Scheltens, E Scarpini, N Hermann, P Mesenbrink, L Mancione, S Tekin, R Lane, S Ferris.
Abstract
The authors investigated neuropsychiatric symptoms in mild cognitive impairment (MCI) from baseline data of the Investigation in the Delay to Diagnosis of AD with Exelon (InDDEx) study (n = 1,010). Neuropsychiatric symptoms were reported in 59% of subjects (Neuropsychiatric Inventory [NPI]). NPI+ subjects had significantly greater impairment on global, cognitive, and functional scores than NPI- subjects. The presence of neuropsychiatric symptoms appears to be a marker of MCI severity.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15079026 DOI: 10.1212/01.wnl.0000118301.92105.ee
Source DB: PubMed Journal: Neurology ISSN: 0028-3878 Impact factor: 9.910